HEMOPHILIA A
Clinical trials for HEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HEMOPHILIA A trials appear
Sign up with your email to follow new studies for HEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study to see if emicizumab protects joints in kids with hemophilia
Disease control Not yet recruitingThis study looks at how emicizumab, a medicine given under the skin, affects the muscles and joints of children with hemophilia A. Researchers will measure pain, joint health, balance, and movement in 20 children under 18. The goal is to understand if this treatment helps prevent…
Matched conditions: HEMOPHILIA A
Sponsor: Hasan Kalyoncu University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New study tracks bleeding prevention in kids with hemophilia a
Disease control Not yet recruitingThis study follows 40 children aged 7 to 12 with hemophilia A who are already prescribed damoctocog alfa pegol, a medicine that replaces missing clotting factor. Researchers will collect information from routine care—like bleeding episodes and health diaries—over two years to see…
Matched conditions: HEMOPHILIA A
Sponsor: Bayer • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New study aims to unlock secrets of immune tolerance in hemophilia a kids
Knowledge-focused Not yet recruitingThis observational study will follow 500 children with hemophilia A who use non-factor therapy to prevent bleeding. Researchers want to understand how the immune system stays tolerant to factor VIII when it is given only occasionally. The study involves yearly blood and stool sam…
Matched conditions: HEMOPHILIA A
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated May 26, 2026 06:15 UTC
-
Gene Therapy's liver impact under the microscope
Knowledge-focused Not yet recruitingThis study looks at liver tissue from adults with hemophilia A or B who received gene therapy at least 6 months ago. Researchers want to see how many liver cells still carry the gene therapy and check for any liver damage. The goal is to learn about the long-term safety of this t…
Matched conditions: HEMOPHILIA A
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
New study to compare bone strength in hemophilia treatments
Knowledge-focused Not yet recruitingThis study looks at bone health in 50 men aged 30-50 with severe hemophilia A who are on one of two long-term treatments: Efanesoctocog alfa or Emicizumab. The goal is to measure changes in bone mineral density over time to see if one treatment is better for bone health. Particip…
Matched conditions: HEMOPHILIA A
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC